JP2024528987A5 - - Google Patents
Info
- Publication number
- JP2024528987A5 JP2024528987A5 JP2024506669A JP2024506669A JP2024528987A5 JP 2024528987 A5 JP2024528987 A5 JP 2024528987A5 JP 2024506669 A JP2024506669 A JP 2024506669A JP 2024506669 A JP2024506669 A JP 2024506669A JP 2024528987 A5 JP2024528987 A5 JP 2024528987A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- cdr1
- cdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163229437P | 2021-08-04 | 2021-08-04 | |
| US63/229,437 | 2021-08-04 | ||
| PCT/US2022/074496 WO2023015225A1 (en) | 2021-08-04 | 2022-08-03 | Anti-pla2g2d constructs and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024528987A JP2024528987A (ja) | 2024-08-01 |
| JP2024528987A5 true JP2024528987A5 (https=) | 2025-08-13 |
Family
ID=85128598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506669A Pending JP2024528987A (ja) | 2021-08-04 | 2022-08-03 | 抗ｐｌａ２ｇ２ｄ構築物およびその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240327540A1 (https=) |
| EP (1) | EP4380690A4 (https=) |
| JP (1) | JP2024528987A (https=) |
| CN (1) | CN118139894A (https=) |
| AU (1) | AU2022323177A1 (https=) |
| CA (1) | CA3178008A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021155305A1 (en) * | 2020-01-30 | 2021-08-05 | Apeximmune Therapeutics Inc. | Methods and compositions for treating cancer or viral infection with a pla2g2d antagonist |
-
2022
- 2022-08-03 JP JP2024506669A patent/JP2024528987A/ja active Pending
- 2022-08-03 AU AU2022323177A patent/AU2022323177A1/en active Pending
- 2022-08-03 US US18/293,765 patent/US20240327540A1/en active Pending
- 2022-08-03 CA CA3178008A patent/CA3178008A1/en active Pending
- 2022-08-03 EP EP22854083.7A patent/EP4380690A4/en active Pending
- 2022-08-03 CN CN202280066768.1A patent/CN118139894A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023543031A5 (https=) | ||
| JP2021508469A5 (https=) | ||
| JP2022515318A5 (https=) | ||
| JP2023529842A5 (https=) | ||
| JP2023516004A5 (https=) | ||
| JP2023536461A5 (https=) | ||
| KR20180004277A (ko) | Pdl-1 항체, 그 약학적 조성물 및 그 용도 | |
| JP2023539501A5 (https=) | ||
| US20250034273A1 (en) | Composition of multispecific antibodies targeting cadherin-17-expressing tumors and method of making and using thereof | |
| JP2022533538A5 (https=) | ||
| CN117946278A (zh) | 多特异性抗体及其制备和使用方法 | |
| JP7679399B2 (ja) | 抗ｆｌｔ３抗体及び組成物 | |
| JP2023549537A5 (https=) | ||
| JP2020533004A5 (https=) | ||
| JP2022553922A5 (https=) | ||
| JP2022545741A5 (https=) | ||
| JP2021525806A5 (https=) | ||
| JP2022532991A5 (https=) | ||
| JP2023516941A5 (https=) | ||
| EP4506360A1 (en) | Anti-pvrig antibody, pharmaceutical composition thereof and use thereof | |
| JP2024054284A (ja) | ガンの処置のための結合分子 | |
| JP2020513759A5 (https=) | ||
| KR20240164815A (ko) | 항-tigit/항-pvrig 이중특이적 항체, 이의 약제학적 조성물 및 이의 용도 | |
| JP2025511289A5 (https=) | ||
| JP2025511288A5 (https=) |